COVID-19 Patient-Reported Symptoms Using FLU-PRO Plus in a Cohort Study: Associations With Infecting Genotype, Vaccine History, and Return to Health

Abstract Background Patient-reported outcomes of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are an important measure of the full burden of coronavirus disease (COVID). Here, we examine how (1) infecting genotype and COVID-19 vaccination correlate with inFLUenza Patient-Re...

Full description

Saved in:
Bibliographic Details
Published in:Open forum infectious diseases 2022-07, Vol.9 (7), p.ofac275-ofac275
Main Authors: Richard, Stephanie A, Epsi, Nusrat J, Lindholm, David A, Malloy, Allison M W, Maves, Ryan C, Berjohn, Catherine M, Lalani, Tahaniyat, Smith, Alfred G, Mody, Rupal M, Ganesan, Anuradha, Huprikar, Nikhil, Colombo, Rhonda E, Colombo, Christopher J, Madar, Cristian, Jones, Milissa U, Larson, Derek T, Ewers, Evan C, Bazan, Samantha, Fries, Anthony C, Maldonado, Carlos J, Simons, Mark P, Rozman, Julia S, Andronescu, Liana, Mende, Katrin, Tribble, David R, Agan, Brian K, Burgess, Timothy H, Pollett, Simon D, Powers, John H
Format: Article
Language:English
Subjects:
Analysis
California
Communicable diseases
Coronaviruses
Epidemics
Epidemiology
Genetic aspects
Health aspects
Influenza
Influenza vaccines
Major
Maryland
Medical research
Medicine, Experimental
Prognosis
Severe acute respiratory syndrome
Texas
Vaccination
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Background Patient-reported outcomes of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are an important measure of the full burden of coronavirus disease (COVID). Here, we examine how (1) infecting genotype and COVID-19 vaccination correlate with inFLUenza Patient-Reported Outcome (FLU-PRO) Plus score, including by symptom domains, and (2) FLU-PRO Plus scores predict return to usual activities and health. Methods The epidemiology, immunology, and clinical characteristics of pandemic infectious diseases (EPICC) study was implemented to describe the short- and long-term consequences of SARS-CoV-2 infection in a longitudinal, observational cohort. Multivariable linear regression models were run with FLU-PRO Plus scores as the outcome variable, and multivariable Cox proportional hazards models evaluated effects of FLU-PRO Plus scores on return to usual health or activities. Results Among the 764 participants included in this analysis, 63% were 18–44 years old, 40% were female, and 51% were White. Being fully vaccinated was associated with lower total scores (β = −0.39; 95% CI, −0.57 to −0.21). The Delta variant was associated with higher total scores (β = 0.25; 95% CI, 0.05 to 0.45). Participants with higher FLU-PRO Plus scores were less likely to report returning to usual health and activities (health: hazard ratio [HR], 0.46; 95% CI, 0.37 to 0.57; activities: HR, 0.56; 95% CI, 0.47 to 0.67). Fully vaccinated participants were more likely to report returning to usual activities (HR, 1.24; 95% CI, 1.04 to 1.48). Conclusions Full SARS-CoV-2 vaccination is associated with decreased severity of patient-reported symptoms across multiple domains, which in turn is likely to be associated with earlier return to usual activities. In addition, infection with the Delta variant was associated with higher FLU-PRO Plus scores than previous variants, even after controlling for vaccination status.
ISSN:2328-8957
2328-8957
DOI:10.1093/ofid/ofac275